论文部分内容阅读
从1983年3月开始应用肝素辅助激素综合治疗难治性肾病,临床观察显示,治疗组总有效率96.8％,其中完全缓解76.2％,部分缓解20.6％,均高于对照组,有显著的统计学意义(x~2=19.4,P<0.01),而两组药物副作用大致相同。通过治疗组自身治疗前后uPr、SAlb、TChol变化对比,各项指标均值有显著性差异(P<0.01)。远期疗效,持续完全缓解率为78％,说明本组临床疗效显著。
From 1983 March began heparin treatment of refractory nephropathy combined nephropathy, clinical observation showed that the total effective rate was 96.8% in the treatment group, of which 76.2% of complete remission, partial response 20.6%, were higher than the control group, with significant statistics Significance (x ~ 2 = 19.4, P <0.01), while the two groups of side effects of drugs are roughly the same. Through the treatment group before and after treatment uPr, SAlb, TChol changes in comparison, the average value of each index was significantly different (P <0.01). Long-term efficacy, sustained and complete remission rate was 78%, indicating that the clinical efficacy of this group was significant.